| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Juana P Sánchez-Villamil | Q92063990 |
| Nisha J Garg | Q87605053 | ||
| Paula Katherine Bautista-Nino | Q85208474 | ||
| P2093 | author name string | Melvin Y Rincon | |
| Norma C Serrano | |||
| P2860 | cites work | Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease | Q89481213 |
| Immunity and vaccine development efforts against Trypanosoma cruzi | Q90077254 | ||
| Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease | Q91069606 | ||
| Parasitic interactions among Trypanosoma cruzi, triatomine vectors, domestic animals, and wildlife in Big Bend National Park along the Texas-Mexico border | Q91386046 | ||
| Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains | Q92711796 | ||
| Multiplicity of effects and health benefits of resveratrol | Q26738735 | ||
| Resveratrol and Cardiovascular Diseases | Q26752801 | ||
| The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease | Q28084634 | ||
| Antioxidants in Translational Medicine | Q28394550 | ||
| Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics | Q28539047 | ||
| Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease | Q28543494 | ||
| Resveratrol Reverses Functional Chagas Heart Disease in Mice | Q28553008 | ||
| Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study | Q28830600 | ||
| Chagas disease | Q29615136 | ||
| Effects of astaxanthin in mice acutely infected with Trypanosoma cruzi | Q30096798 | ||
| Mitochondrial complex III defects contribute to inefficient respiration and ATP synthesis in the myocardium of Trypanosoma cruzi-infected mice | Q33649904 | ||
| Pathogenesis of Chronic Chagas Disease: Macrophages, Mitochondria, and Oxidative Stress | Q88988590 | ||
| Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart disease | Q33773325 | ||
| Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes | Q33799832 | ||
| Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats | Q33921202 | ||
| Melatonin: action as antioxidant and potential applications in human disease and aging | Q34111973 | ||
| Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats. | Q34112124 | ||
| Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation | Q34228648 | ||
| A review of the evidence supporting melatonin's role as an antioxidant | Q34312720 | ||
| Would selenium supplementation aid in therapy for Chagas disease? | Q34629025 | ||
| Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity | Q34675951 | ||
| Innate immune responses and antioxidant/oxidant imbalance are major determinants of human Chagas disease | Q34952422 | ||
| Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. | Q35085050 | ||
| NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease | Q35230292 | ||
| Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease. | Q35569849 | ||
| The Combination of Vitamin K3 and Vitamin C Has Synergic Activity against Forms of Trypanosoma cruzi through a Redox Imbalance Process | Q35862244 | ||
| Oxidative stress fuels Trypanosoma cruzi infection in mice | Q36068270 | ||
| SIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease | Q36169626 | ||
| Epidemiology and Molecular Typing of Trypanosoma cruzi in Naturally-Infected Hound Dogs and Associated Triatomine Vectors in Texas, USA | Q36251494 | ||
| Defects of mtDNA replication impaired mitochondrial biogenesis during Trypanosoma cruzi infection in human cardiomyocytes and chagasic patients: the role of Nrf1/2 and antioxidant response | Q36519814 | ||
| Curcumin treatment provides protection against Trypanosoma cruzi infection | Q36566715 | ||
| Antioxidant activity of carvedilol in cardiovascular disease | Q36757192 | ||
| Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease | Q36933422 | ||
| Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice | Q37036989 | ||
| S-Nitrosylation Proteome Profile of Peripheral Blood Mononuclear Cells in Human Heart Failure | Q37223016 | ||
| Chemotherapeutic efficacy of phosphodiesterase inhibitors in chagasic cardiomyopathy. | Q37341337 | ||
| Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes. | Q37399631 | ||
| Chagas' heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance | Q37444455 | ||
| Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review | Q37566186 | ||
| Antioxidant therapy effectiveness: an up to date. | Q37582893 | ||
| Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes | Q37653023 | ||
| Expert consensus document: Mitochondrial function as a therapeutic target in heart failure | Q37699474 | ||
| Targeting AMPK for cardiac protection: opportunities and challenges | Q37819301 | ||
| ROS signalling of inflammatory cytokines during Trypanosoma cruzi infection | Q37925212 | ||
| Mitochondria and trypanosomatids: targets and drugs | Q37936341 | ||
| Resveratrol and endothelial nitric oxide. | Q38258814 | ||
| Antioxidant and pro-oxidant activity of Vitamin C in oral environment | Q38259415 | ||
| Oxidative stress and myocarditis | Q38676830 | ||
| Current drug therapy and pharmaceutical challenges for Chagas disease | Q38690782 | ||
| Antioxidant effects of resveratrol in the cardiovascular system. | Q38802176 | ||
| Metformin as a Tool to Target Aging | Q38865781 | ||
| Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. | Q38957154 | ||
| Molecular identification and genotyping of Trypanosoma cruzi DNA in autochthonous Chagas disease patients from Texas, USA. | Q39017209 | ||
| Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy | Q39269382 | ||
| Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection | Q39419338 | ||
| Induction of NADPH oxidase activity and reactive oxygen species production by a single Trypanosoma cruzi antigen. | Q39679397 | ||
| Evaluation of antioxidant therapy in experimental Chagas disease | Q40190859 | ||
| Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine | Q40284629 | ||
| Nonsteroidal anti-inflammatory is more effective than anti-oxidant therapy in counteracting oxidative/nitrosative stress and heart disease in T. cruzi-infected mice. | Q40353829 | ||
| Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease. | Q40354504 | ||
| Interleukin-17, oxidative stress, and inflammation: role of melatonin during Trypanosoma cruzi infection | Q40968042 | ||
| EFFECTS OF VITAMIN C SUPPLEMENTATION ON THE CHRONIC PHASE OF CHAGAS DISEASE. | Q41095664 | ||
| Experimental and Clinical Treatment of Chagas Disease: A Review. | Q41989175 | ||
| Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease | Q42135513 | ||
| Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes | Q43599449 | ||
| Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity | Q43628443 | ||
| Time-dependent oxidative stress caused by benznidazole | Q43772433 | ||
| Melatonin improves deferoxamine antioxidant activity in protecting against lipid peroxidation caused by hydrogen peroxide in rat brain homogenates | Q43930997 | ||
| Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals | Q44386996 | ||
| Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense | Q45140382 | ||
| Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease. | Q45922852 | ||
| Chagas disease: a new worldwide challenge. | Q45935390 | ||
| Carvedilol attenuates oxidative stress in chronic chagasic cardiomyopathy. | Q46459222 | ||
| Antioxidant effect of Morus nigra on Chagas disease progression | Q47104030 | ||
| Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development | Q47345530 | ||
| Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease. | Q50703678 | ||
| Alterations of mitochondria in liver but not in heart homogenates after treatment of rats with benznidazole. | Q51162806 | ||
| Impact of the Use of Benznidazole Followed by Antioxidant Supplementation in the Prevalence of Ventricular Arrhythmias in Patients With Chronic Chagas Disease: Pilot Study. | Q51388716 | ||
| Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. | Q53652238 | ||
| Paradoxical effects of vitamin C in Chagas disease. | Q54219334 | ||
| Pentose Phosphate Shunt Modulates Reactive Oxygen Species and Nitric Oxide Production Controlling Trypanosoma cruzi in Macrophages. | Q55040558 | ||
| Pathology and Pathogenesis of Chagas Heart Disease | Q57789637 | ||
| Desferrioxamine reduces oxidative stress in the lung contusion | Q57961284 | ||
| The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi | Q58599638 | ||
| Mitochondria as a therapeutic target for common pathologies | Q58611546 | ||
| Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi | Q58703394 | ||
| Oxidative stress in chronic cardiopathy associated with Chagas disease | Q58844973 | ||
| Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients | Q58845248 | ||
| A Review of Curcumin and Its Derivatives as Anticancer Agents | Q64095593 | ||
| The Role of Curcumin in the Modulation of Ageing | Q64103363 | ||
| Study of reproducibility of spin trapping results in the use of C-phenyl-N-tert-butyl nitrone (PBN) for trichloromethyl radical detection in CCl4 metabolism by rat liver microsomal dispersions. Biological spin trapping I | Q72116141 | ||
| Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages | Q72858681 | ||
| Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi | Q73403138 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | Chagas disease | Q649558 |
| P304 | page(s) | 9081813 | |
| P577 | publication date | 2020-03-26 | |
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease | |
| P478 | volume | 2020 |
Search more.